PT 141

PT-141, or bremelanotide, is a synthetic peptide therapy used to treat sexual dysfunction in both men and women by targeting the central nervous system to increase libido. Unlike drugs that act on vascular systems, PT-141 activates melanocortin receptors in the brain to increase desire and sexual arousal.

• Enhances sexual desire (libido): Works centrally in the nervous system to increase interest in sexual activity.

• Supports arousal in both men and women: Not limited to vascular mechanisms.

• Hypoactive Sexual Desire Disorder (HSDD): Approved (as Bremelanotide) for premenopausal women with low sexual desire.

• Erectile dysfunction support: Used off-label in men, especially when psychological or neurological factors are involved.

• Bremelanotide

• Bremelanotide acetate

• There are no long-term human studies, and these peptides are not approved by the FDA, with potential risks unknown.

• They are often sourced through specialized, clinician-guided, or anti-aging, clinics.